These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

508 related articles for article (PubMed ID: 32272433)

  • 1. Prevalence and correlation of glycemic control achievement in patients with type 2 diabetes in Iraq: A retrospective analysis of a tertiary care database over a 9-year period.
    Mansour AA; Alibrahim NTY; Alidrisi HA; Alhamza AH; Almomin AM; Zaboon IA; Kadhim MB; Hussein RN; Nwayyir HA; Mohammed AG; Al-Waeli DKJ; Hussein IH;
    Diabetes Metab Syndr; 2020; 14(3):265-272. PubMed ID: 32272433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of inadequate glycemic control among patients with type 2 diabetes in the United Kingdom general practice research database: A series of retrospective analyses of data from 1998 through 2002.
    Fox KM; Gerber Pharmd RA; Bolinder B; Chen J; Kumar S
    Clin Ther; 2006 Mar; 28(3):388-95. PubMed ID: 16750453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antidiabetic prescriptions and glycemic control in German patients with type 2 diabetes mellitus: a retrospective database study.
    Yurgin N; Secnik K; Lage MJ
    Clin Ther; 2007 Feb; 29(2):316-25. PubMed ID: 17472823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and Economic Outcomes of Patients with Type 2 Diabetes on Multiple Daily Injections of Basal-bolus Insulin (MDI) Therapy: A Retrospective Cohort Study.
    Brixner D; Ermakova A; Xiong Y; Sieradzan R; Sacks N; Cyr P; Taylor SD
    Clin Ther; 2019 Feb; 41(2):303-313.e1. PubMed ID: 30709610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of baseline characteristics, glycemic control and oral antidiabetic treatment in Asian patients with diabetes: The Registry for Assessing OAD Usage in Diabetes Management (REASON) Asia study.
    Vichayanrat A; Matawaran BJ; Wibudi A; Ferdous HS; Aamir AH; Aggarwal SK; Bajpai S
    J Diabetes; 2013 Sep; 5(3):309-18. PubMed ID: 23462227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of poor glycemic control among type 2 diabetes mellitus patients treated with antidiabetic medications: A cross-sectional study in China.
    Wang J; Li J; Wen C; Liu Y; Ma H
    Medicine (Baltimore); 2021 Oct; 100(43):e27677. PubMed ID: 34713865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patient characteristics and 6-month dose of basal insulin associated with HbA1c achievement <7.0% in Chinese people with type 2 diabetes: results from the Observational Registry of Basal Insulin Treatment (ORBIT).
    Gao L; Zhang P; Weng J; Lu J; Guo X; Jia W; Yang W; Zou D; Zhou Z; Pan C; Gao Y; Li X; Zhu D; Wu Y; Garg SK; Ji L
    J Diabetes; 2020 Sep; 12(9):668-676. PubMed ID: 32329194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glycemic control and diabetic dyslipidemia in adolescents with type 2 diabetes.
    Le PT; Huisingh CE; Ashraf AP
    Endocr Pract; 2013; 19(6):972-9. PubMed ID: 23807519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in Antidiabetic Drug Prescription and Glycemic Control Trends in Elderly Patients with Type 2 Diabetes Mellitus from 2005-2013: An Analysis of the National Center Diabetes Database (NCDD-03).
    Yamamoto-Honda R; Takahashi Y; Mori Y; Yamashita S; Yoshida Y; Kawazu S; Iwamoto Y; Kajio H; Yanai H; Mishima S; Handa N; Shimokawa K; Yoshida A; Watanabe H; Ohe K; Shimbo T; Noda M
    Intern Med; 2018 May; 57(9):1229-1240. PubMed ID: 29279487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of telemedicine on glycemic control in type 2 diabetes mellitus during the COVID-19 lockdown period.
    Al-Mutairi AM; Alshabeeb MA; Abohelaika S; Alomar FA; Bidasee KR
    Front Endocrinol (Lausanne); 2023; 14():1068018. PubMed ID: 36817609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prevalence of type 2 diabetes mellitus in overweight or obese outpatients in Spain. OBEDIA Study].
    Gomis R; Artola S; Conthe P; Vidal J; Casamor R; Font B;
    Med Clin (Barc); 2014 Jun; 142(11):485-92. PubMed ID: 23683969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessing achievement and maintenance of glycemic control by patients initiating basal insulin.
    Wu N; Aagren M; Boulanger L; Friedman M; Wilkey K
    Curr Med Res Opin; 2012 Oct; 28(10):1647-56. PubMed ID: 22937724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patterns of drug therapy, glycemic control, and predictors of escalation - non-escalation of treatment among diabetes outpatients at a tertiary care center.
    Atal S; Joshi R; Misra S; Fatima Z; Sharma S; Balakrishnan S; Singh P
    J Basic Clin Physiol Pharmacol; 2022 Nov; 33(6):803-814. PubMed ID: 34449177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Real-Life Glycemic Control in Children with Type 2 Diabetes: A Population-Based Study.
    Meyerovitch J; Zlotnik M; Yackobovitch-Gavan M; Phillip M; Shalitin S
    J Pediatr; 2017 Sep; 188():173-180.e1. PubMed ID: 28693789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation between baseline characteristics and clinical outcomes in a large population of diabetes patients treated with liraglutide in a real-world setting in Italy.
    Lapolla A; Frison V; Bettio M; Dal Pos M; Rocchini P; Panebianco G; Tadiotto F; Da Tos V; D'Ambrosio M; Marangoni A; Ferrari M; Pianta A; Balzano S; Confortin L; Lamonica M; Marin N; Strazzabosco M; Brun E; Mesturino CA; Simoncini M; Zen F; Bax G; Bonsembiante B; Cardone C; Dal Frà MG; Gallo A; Masin M; Piarulli F; Sartore G; Simioni N
    Clin Ther; 2015 Mar; 37(3):574-84. PubMed ID: 25626486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Baseline and 1-year interim follow-up assessment of Japanese patients initiating insulin therapy who were enrolled in the cardiovascular risk evaluation in people with type 2 diabetes on insulin therapy study: an international, multicenter, observational study.
    Kawamori R; Node K; Hanafusa T; Atsumi Y; Naito Y; Oka Y
    Cardiovasc Diabetol; 2013 Sep; 12():131. PubMed ID: 24011395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Real-world Canagliflozin Utilization: Glycemic Control Among Patients With Type 2 Diabetes Mellitus-A Multi-Database Synthesis.
    Chow W; Miyasato G; Kokkotos FK; Bailey RA; Buysman EK; Henk HJ
    Clin Ther; 2016 Sep; 38(9):2071-82. PubMed ID: 27596020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors Associated with Diabetes Control in Predominately African American and Hispanic Population with Newly Diagnosed Type 2 Diabetes.
    Morkos M; Tahsin B; Fogelfeld L
    J Racial Ethn Health Disparities; 2021 Apr; 8(2):332-338. PubMed ID: 32557276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved Clinical Outcomes with Dulaglutide as Add-on Medication to Oral Antidiabetic Drugs with or Without Insulin in Overweight Indian Patients with Type 2 Diabetes Mellitus: Retrospective Study in a Real-World Setting.
    Ghosh A; Nair R
    Curr Diabetes Rev; 2020; 16(5):490-496. PubMed ID: 31686642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of premixed insulin to achieve glycaemic control in type 2 diabetes: A retrospective UK cohort study.
    Jude EB; Trescoli C; Emral R; Ali A; Lubwama R; Palmer K; Shaunik A; Nanda N; Raskin P; Gomez-Peralta F
    Diabetes Obes Metab; 2021 Apr; 23(4):929-937. PubMed ID: 33319424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.